OTC Markets OTCPK - Delayed Quote USD

Alterity Therapeutics Limited (PRNAF)

0.0139
0.0000
(0.00%)
At close: May 14 at 4:00:00 PM EDT
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
20,024.9990
19,402.3170
14,351.0750
15,137.3220
14,738.6920
Operating Income
-20,024.9990
-19,402.3170
-14,351.0750
-15,137.3220
-14,738.6920
Net Non Operating Interest Income Expense
261.3180
268.4190
16.4360
2.5040
20.6760
Other Income Expense
20.1530
56.5220
649.7330
2,357.7650
-591.3370
Pretax Income
-19,743.5280
-19,077.3760
-13,702.0560
-12,777.0530
-15,309.3530
Tax Provision
46.0880
46.0880
104.4590
70.0080
0
Net Income Common Stockholders
-19,789.6160
-19,123.4640
-13,806.5150
-12,847.0610
-15,309.3530
Diluted NI Available to Com Stockholders
-19,789.6160
-19,123.4640
-13,806.5150
-12,847.0610
-15,309.3530
Basic EPS
-0.00
-0.01
-0.00
-0.01
-0.01
Diluted EPS
-0.00
-0.01
-0.00
-0.01
-0.01
Basic Average Shares
5,053,947.9900
3,648,875.5640
14,567,057.3290
2,405,990.0360
1,696,876.3240
Diluted Average Shares
5,053,947.9900
3,648,875.5640
14,567,057.3290
2,405,990.0360
1,696,876.3240
Rent Expense Supplemental
--
--
68.6340
79.3290
87.6120
Total Expenses
20,024.9990
19,402.3170
14,351.0750
15,137.3220
14,738.6920
Net Income from Continuing & Discontinued Operation
-19,789.6160
-19,123.4640
-13,806.5150
-12,847.0610
-15,309.3530
Normalized Income
-19,926.8734
-19,306.2704
-14,460.8750
-14,752.7620
-15,078.0420
Interest Income
261.3180
268.4190
16.4360
2.5040
20.6760
Net Interest Income
261.3180
268.4190
16.4360
2.5040
20.6760
EBIT
-20,024.9990
-19,402.3170
-14,351.0750
-15,137.3220
-14,738.6920
EBITDA
-19,878.7980
-19,254.7880
-14,248.8120
-15,083.1080
-14,663.3230
Reconciled Depreciation
146.2010
147.5290
102.2630
54.2140
75.3690
Net Income from Continuing Operation Net Minority Interest
-19,789.6160
-19,123.4640
-13,806.5150
-12,847.0610
-15,309.3530
Total Unusual Items Excluding Goodwill
196.0820
261.1520
934.8000
2,722.4300
-231.3110
Total Unusual Items
196.0820
261.1520
934.8000
2,722.4300
-231.3110
Normalized EBITDA
-20,074.8800
-19,515.9400
-15,183.6120
-17,805.5380
-14,432.0120
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0
Tax Effect of Unusual Items
58.8246
78.3456
280.4400
816.7290
0
6/30/2021 - 9/25/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CALC CalciMedica, Inc.
1.9130
-0.88%
 
SRZN Surrozen, Inc.
6.50
-9.72%
 
FENC Fennec Pharmaceuticals Inc.
6.33
-2.31%
 
LENZ LENZ Therapeutics, Inc.
27.63
-4.59%
 
TIL Instil Bio, Inc.
13.29
+4.32%
 
CING Cingulate Inc.
4.2500
+8.70%
 
IRD Opus Genetics, Inc.
0.9500
-0.96%
 
SLS SELLAS Life Sciences Group, Inc.
1.5100
+7.09%
 
ANVS Annovis Bio, Inc.
1.6900
-0.59%
 
BIVI BioVie Inc.
1.1000
+2.80%